These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33205836)

  • 1. Pityriasis rosea and COVID-19.
    Veraldi S; Spigariolo CB
    J Med Virol; 2021 Jul; 93(7):4068. PubMed ID: 33205836
    [No Abstract]   [Full Text] [Related]  

  • 2. Human herpesvirus-6, -7, and Epstein-Barr virus reactivation in pityriasis rosea during COVID-19.
    Drago F; Ciccarese G; Rebora A; Parodi A
    J Med Virol; 2021 Apr; 93(4):1850-1851. PubMed ID: 32970319
    [No Abstract]   [Full Text] [Related]  

  • 3. Pityriasis Rosea after COVID-19 Infection.
    Prtajin M; Ljubojević Hadžavdić S
    Acta Dermatovenerol Croat; 2022 Dec; 30(4):265-266. PubMed ID: 36919396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pityriasis Rosea Shortly After mRNA-1273 COVID-19 Vaccination.
    Shin SH; Hong JK; Hong SA; Li K; Yoo KH
    Int J Infect Dis; 2022 Jan; 114():88-89. PubMed ID: 34740803
    [No Abstract]   [Full Text] [Related]  

  • 5. SARS-CoV-2 spike protein positivity in pityriasis rosea-like and urticaria-like rashes of COVID-19.
    Welsh E; Cardenas-de la Garza JA; Cuellar-Barboza A; Franco-Marquez R; Arvizu-Rivera RI
    Br J Dermatol; 2021 Jun; 184(6):1194-1195. PubMed ID: 33511657
    [No Abstract]   [Full Text] [Related]  

  • 6. Manifestation of pityriasis rosea and pityriasis rosea-like eruptions after Covid-19 vaccine: A systematic review.
    Khan I; Elsanousi AA; Shareef AM; Tebha SS; Arif A; Gul S
    Immun Inflamm Dis; 2023 Apr; 11(4):e804. PubMed ID: 37102660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contemporary occurrence of Chilblain-like lesions and Pityriasis rosea during the COVID-19 pandemic.
    Piccolo V; Bassi A; Argenziano G; Mazzatenta C; Cutrone M; Neri I; Grimalt R; Russo T
    J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):e619-e620. PubMed ID: 34050995
    [No Abstract]   [Full Text] [Related]  

  • 8. Pityriasis rosea like eruption: A dermatological manifestation of Coronavac-COVID-19 vaccine.
    Gökçek GE; Öksüm Solak E; Çölgeçen E
    Dermatol Ther; 2022 Feb; 35(2):e15256. PubMed ID: 34881483
    [No Abstract]   [Full Text] [Related]  

  • 9. Can COVID-19 cause atypical forms of pityriasis rosea refractory to conventional therapies?
    Martora F; Picone V; Fornaro L; Fabbrocini G; Marasca C
    J Med Virol; 2022 Apr; 94(4):1292-1293. PubMed ID: 34931329
    [No Abstract]   [Full Text] [Related]  

  • 10. Post Covid-19 vaccination papulovesicular pityriasis rosea-like eruption in a young male.
    Adya KA; Inamadar AC; Albadri W
    Dermatol Ther; 2021 Sep; 34(5):e15040. PubMed ID: 34165237
    [No Abstract]   [Full Text] [Related]  

  • 11. Atypical pityriasis rosea associated with mRNA COVID-19 vaccine.
    Bostan E; Jarbou A
    J Med Virol; 2022 Mar; 94(3):814-816. PubMed ID: 34585750
    [No Abstract]   [Full Text] [Related]  

  • 12. Pityriasis rosea Gibert type rash in an asymptomatic patient that tested positive for COVID-19.
    Martín Enguix D; Salazar Nievas MDC; Martín Romero DT
    Med Clin (Barc); 2020 Sep; 155(6):273. PubMed ID: 32654832
    [No Abstract]   [Full Text] [Related]  

  • 13. Pityriasis rosea after mRNA COVID-19 vaccination.
    Abdullah L; Hasbani D; Kurban M; Abbas O
    Int J Dermatol; 2021 Sep; 60(9):1150-1151. PubMed ID: 34110010
    [No Abstract]   [Full Text] [Related]  

  • 14. The clinics of HHV-6 infection in COVID-19 pandemic: Pityriasis rosea and Kawasaki disease.
    Dursun R; Temiz SA
    Dermatol Ther; 2020 Jul; 33(4):e13730. PubMed ID: 32475003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pityriasis rosea following SARS-CoV-2 vaccination: A case series.
    Temiz SA; Abdelmaksoud A; Dursun R; Durmaz K; Sadoughifar R; Hasan A
    J Cosmet Dermatol; 2021 Oct; 20(10):3080-3084. PubMed ID: 34363731
    [No Abstract]   [Full Text] [Related]  

  • 16. Maculopapular eruptions following COVID-19 vaccination: Pityriasis rosea or pityriasis rosea-like eruptions?
    Ciccarese G; Mastrolonardo M; Serviddio G; Drago F
    J Cosmet Dermatol; 2023 Sep; 22(9):2380-2381. PubMed ID: 37382032
    [No Abstract]   [Full Text] [Related]  

  • 17. Reply to "the significance of investigating clinical, histopathologic and virological features in pityriasis rosea and pityriasis rosea-like eruptions following COVID-19 vaccinations" by Ciccarese G. et al.
    Martora F; Picone V; Battista T; Fabbrocini G; Marasca C
    Dermatol Ther; 2022 Aug; 35(8):e15602. PubMed ID: 35622446
    [No Abstract]   [Full Text] [Related]  

  • 18. An update on pityriasis rosea and other similar childhood exanthems.
    Browning JC
    Curr Opin Pediatr; 2009 Aug; 21(4):481-5. PubMed ID: 19502983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pityriasis rosea.
    Hartley AH
    Pediatr Rev; 1999 Aug; 20(8):266-9, quiz 270. PubMed ID: 10429145
    [No Abstract]   [Full Text] [Related]  

  • 20. Pityriasis Rosea Associated With COVID-19 Vaccination: A Common Rash Following Administration of a Novel Vaccine.
    Valk B; Bender B
    Cutis; 2021 Dec; 108(6):317-318. PubMed ID: 35167784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.